Misoprostol vs placebo
Acute and late GI toxicity (grade 2+) · Men with prostate cancer
Summary of findings: Misoprostol showed no clear difference in acute and late GI toxicity (grade 2+) compared with placebo (low certainty).
1 finding from 1 review
- Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic… 2018 · Cochrane Headline outcomes onlyRR 1.38 [0.76, 2.51]1 study · 100 participantsLow